Vicore Pharma Holding AB (publ) reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net loss was SEK 69.2 million compared to SEK 65.87 million a year ago. Basic loss per share from continuing operations was SEK 0.85 compared to SEK 0.92 a year ago.
For the six months, net loss was SEK 135.49 million compared to SEK 159.24 million a year ago. Basic loss per share from continuing operations was SEK 1.64 compared to SEK 2.22 a year ago.